Abstract
Surgery for intramedullary spinal cord tumors, especially intramedullary spinal cord astrocytomas, is associated with a high risk of new postoperative neurologic deficit. While the literature supports the role of intraoperative neurophysiological monitoring (INM) in intramedullary spinal cord tumor (ISCT) surgery, it remains unclear whether different histotypes of ISCT benefit of INM to a different extend. We therefore retrospectively analyzed the functional and neurooncological outcome in a series of spinal cord astrocytomas operated on under INM assistance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
